The Senate Finance Committee yesterday introduced 22 bipartisan bills to address the opioid crisis in Medicare, Medicaid and human services programs. The Medicaid-related bills include provisions related to inpatient treatment services furnished in institutions for mental disease and medical assistance to infants with neonatal abstinence syndrome, among other issues. The Medicare bills include provisions to educate Medicare beneficiaries about opioid use and pain management and screen for potential substance use disorders; expand telehealth use for SUDs; require e-prescribing of controlled substances and electronic prior authorization under Part D; and impose certain requirements with respect to outlier opioid prescribers. Committee leaders expect to schedule a markup on the bills and possibly additional proposals in the coming weeks.

Related News Articles

Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The AHA Sept. 3 released a study conducted by KNG Health Consulting that found Medicare patients who receive care in a hospital outpatient department are more…
Headline
The AHA Aug. 28 expressed support for the Preserving Patient Access to Accountable Care Act in comments to House and Senate sponsors of the bill. The…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the…